Vanda Pharmaceuticals Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
Latest Filings
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Vanda Pharmaceuticals Inc.
CIK #0001347178
EDGAR Form CIK 2011 - 2024
10-K [0001347178]
10-Q [0001347178]
3 [0001347178]
4 [0001347178]
5 [0001347178]
8-K [0001347178]
SC 13G [0001347178]
Form 13D/13G Filer Form 13D/13G Subject Filed
Dimensional Fund Advisors LP Vanda Pharmaceuticals Inc [2023-02-10]
State Street Corp Vanda Pharmaceuticals Inc [2021-02-11]
BlackRock Inc Vanda Pharmaceuticals Inc [2021-01-25]
Renaissance Technologies LLC Vanda Pharmaceuticals Inc [2020-02-12]
Armistice Capital LLC Vanda Pharmaceuticals Inc [2019-06-24]
Consonance Capital Management LP Vanda Pharmaceuticals Inc [2019-02-14]
Macquarie Group Ltd Vanda Pharmaceuticals Inc [2018-02-14]
Vanguard Group Inc Vanda Pharmaceuticals Inc [2018-02-09]
Armistice Capital LLC Vanda Pharmaceuticals Inc [2017-06-19]
Integrated Core Strategies US LLC Vanda Pharmaceuticals Inc [2016-01-27]
View All
Form 3/4/5 Subject 2011 - 2024
Vanda Pharmaceuticals Inc.
Moran Kevin Patrick
Chrousos Phaedra
Honore Tage
Ward Anne Sempowski
Mitchell Stephen Ray
Dugan Richard W
Williams Timothy
Birznieks Gunther
Polymeropoulos Mihael Hristos
Wijkstrom Joakim
Watkins Thomas
Jones Aranthan II
Kelly James Patrick
Reverberi Gian Piero
Cola Michael F
Milano Vincent
Gulino Richard L.
Bate Kenneth
Flynn James E
Deerfield Mgmt L.P.
Deerfield Partners LP
Deerfield Special Situations Fund, L.P.
Deerfield Management Company LP Series C
Deerfield International Master Fund, L.P.
Baroldi Paolo
Pien Howard H
Gibbs Thomas Edward
Deerfield Special Situations International Master Fund, L.P.
Galson Steven K
Repella Robert
Feeney John Joseph
Terms | Privacy | Guide
tony@aum13f.com